Biochem/physiol Actions
BPK-29 is a potent and selective NR0B1 ligand that covalently binds to NR0B1 Cys 274. BPK-29 inhibits the NR0B1-SNW1 interaction. It inhibits the anchorage-independent growth of KEAP1-mutant cancer cells.
BPK-29 is a small molecule inhibitor that blocks the nuclear factor erythroid 2–related factor 2 (NRF2) pathway. It targets the cysteine 274 residue in the nuclear receptor subfamily 0 group B member 1 (NR0B1) and disrupts protein-protein interactions in non-small-cell lung cancer (NSCLC) cell proteomes.
- UPC:
- 12141723
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML2305-5MG
- CAS:
- 2143467-62-1
akash.verma@cenmed.com
(732) 447-1115





